Showing results (61-70 of 115) with videos related to
Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort StudyKhitam Muhsen, Nimrod Maimon, Ami Mizrahi, et al.Foodborne Pathogens and Disease|July 2, 2010
Phenotypic characteristics of enterotoxigenic Escherichia coli associated with acute diarrhea among Israeli young adultsDani Cohen, Joshua Tobias, Anya Spungin-Bialik, et al.Vaccines|March 28, 2024
IgG Serum Antibodies to <i>Shigella sonnei</i> Lipopolysaccharide Are Inversely Associated with the Incidence of Culture-Proven <i>S. sonnei</i> Shigellosis in Israeli Children and AdolescentsValeria Asato, Ravit Bassal, Shiri Meron-Sudai, et al.Human Vaccines & Immunotherapeutics|September 9, 2024
Factors associated with antibiotic use in children hospitalized for acute viral gastroenteritis and the relation to rotavirus vaccinationMuna Omar, Eias Kassem, Emilia Anis, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infectionArmelle Phalipon, Myriam Tanguy, Cyrille Grandjean, et al.Influenza and Other Respiratory Viruses|January 3, 2013
The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in IsraelMerav Weil, Tamar Shohat, Michal Bromberg, et al.Frontiers in Immunology|November 29, 2023
Further characterization of <i>Shigella</i>-specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a <i>Shigella flexneri</i> 2a synthetic glycan-based vaccine candidateFranklin R Toapanta, Jingping Hu, Shiri Meron-Sudai, et al.Human Vaccines & Immunotherapeutics|July 28, 2015
A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in IsraelKhitam Muhsen, Uri Rubenstein, Eias Kassem, et al.The Lancet Regional Health. Europe|June 10, 2021
A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020-February 2021Khitam Muhsen, Wasef Na'aminh, Yelena Lapidot, et al.Vaccine|January 31, 2012
Risk factors of underutilization of childhood immunizations in ultraorthodox Jewish communities in Israel despite high access to health care servicesKhitam Muhsen, Reem Abed El-Hai, Anat Amit-Aharon, et al.Pageof 12